Another bibenzyl derivative, moscatilin, has been reported to activate JNK signaling and trigger DNA damage in colorectal cancer cells [47], while promoting apoptosis via JNK activation in head and neck carcinoma and pancreatic cancer models [48,49]. The gene discussed is MAPK8; the disease is pancreatic neoplasm.